Sort   by:  
 Page size 
UnknownLack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer.
Not available
S-EPMC7399239 | biostudies-literature
UnknownComparison of five different disseminated intravascular coagulation criteria in predicting mortality in patients with sepsis.
Not available
S-EPMC10919643 | biostudies-literature
UnknownPhytochemical Profiling, Anti-Inflammatory, Anti-Oxidant and In-Silico Approach of Cornus macrophylla Bioss (Bark).
Not available
S-EPMC9268425 | biostudies-literature
UnknownAntibacterial and antibiofilm potentials of Rumex dentatus root extract characterized by HPLC-ESI-Q-TOF-MS.
Not available
S-EPMC10899039 | biostudies-literature
UnknownExpression of Androgen Receptor and Cancer Stem Cell Markers (CD44+/CD24- and ALDH1+): Prognostic Implications in Invasive Breast Cancer.
Not available
S-EPMC6041567 | biostudies-literature
UnknownThe SARS-CoV-2 differential genomic adaptation in response to varying UVindex reveals potential genomic resources for better COVID-19 diagnosis and prevention.
Not available
S-EPMC9396647 | biostudies-literature
UnknownIn silico identification and evaluation of leads for the simultaneous inhibition of protease and helicase activities of HCV NS3/4A protease using complex based pharmacophore mapping and virtual screening.
Not available
S-EPMC3923879 | biostudies-literature
UnknownExpression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients.
Not available
S-EPMC8955648 | biostudies-literature
UnknownElrexfio™ (elranatamab-bcmm): The game-changer in treatment of multiple myeloma.
Not available
S-EPMC10571667 | biostudies-literature
UnknownRevolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa.
Not available
S-EPMC10718329 | biostudies-literature
Sort   by:  
 Page size